American Academy of Pediatrics. (2022). Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics, 150(3), e2022058859.
[2]
Dennery, P. A., Seidman, D. S., & Stevenson, D. K. (2021). Neonatal Hyperbilirubinemia. New England Journal of Medicine, 384(24), 2311-2320.
[3]
Watchko, J. F., & Tiribelli, C. (2023). Bilirubin-Induced Neurologic Damage — Mechanisms and Management Approaches. New England Journal of Medicine, 389(18), 1691-1703.
[4]
Olusanya, B. O., et al. (2020). Management of Neonatal Jaundice in Low- and Middle-Income Countries. Paediatrics and International Child Health, 40(4), 215-224.
[5]
Kemper, A. R., et al. (2021). Update on Kernicterus: Seeking Simpler Solutions for a Complex Problem. Journal of Perinatology, 41(5), 1015-1023.
[6]
Hansen, T. W. R., et al. (2022). Prevention of Severe Neonatal Hyperbilirubinemia: A Global Perspective. Pediatric Research, 91(7), 1614-1621.
[7]
World Health Organization. (2023). Guidelines for the Management of Neonatal Jaundice. WHO Publications.
[8]
Shapiro, S. M., et al. (2020). Chronic Bilirubin Encephalopathy: Diagnosis and Outcome. Seminars in Fetal & Neonatal Medicine, 25(3), 101-110.